Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer-Reference-Cited by-同舟云学术

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer

Published:2013-06-05 Issue:13 Volume:105 Page:960-967
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Loi Sherene,Michiels Stefan,Lambrechts Diether,Fumagalli Debora,Claes Bart,Kellokumpu-Lehtinen Pirkko-Liisa,Bono Petri,Kataja Vesa,Piccart Martine J.,Joensuu Heikki,Sotiriou Christos

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/13/960/17312289/djt121.pdf

Reference53 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Targeting PI3K signalling in cancer: opportunities, challenges and limitations;Engelman;Nat Rev Cancer,2009

4. PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups;Cizkova;Breast Cancer Res,2012

5. PIK3CA mutation associates with improved outcome in breast cancer;Kalinsky;Clin Cancer Res,2009

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGM1/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation;Cell Reports;2024-08

2. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11

3. Trastuzumab Response in Iraqi Women with Her2 Positive Breast Cancer: The Role of PIK3CA Oncogene Mutations at E542k and E545k;MED BALEAR;2024

4. Oncoproteomics by 3D MALDI with MRI-PET Imaging in Cancer;Pharmacoproteomics;2024

5. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer;JAMA Network Open;2023-12-20